Wells Fargo & Company 13D and 13G filings for Opiant Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-27 10:12 am Sale | 2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | WELLS FARGO & COMPANY WFC | 224,297 4.750% | -27,908 (-11.07%) | Filing |
| 2021-02-11 4:37 pm Purchase | 2020-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT | WELLS FARGO & COMPANY WFC | 252,205 5.920% | 252,205 (New Position) | Filing |